Sarah Cash
Adult Health · Riverview, FLNPI 1295133866
Payments from drug & device makers
Across 291 payments — averaging $21.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$799
- Neuronetics, Inc.$756
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$709
- Otsuka America Pharmaceutical, Inc.$606
- Supernus Pharmaceuticals, Inc.$513
- Tris Pharma Inc$434
- plus $2K from 22 others
What the payments were for
- Food & beverage$6,20299%
- Education$611%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $799 |
| Neuronetics, Inc. | 9 | $756 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $709 |
| Otsuka America Pharmaceutical, Inc. | 25 | $606 |
| Supernus Pharmaceuticals, Inc. | 54 | $513 |
| Tris Pharma Inc | 29 | $434 |
| Axsome Therapeutics, Inc. | 9 | $316 |
| Corium, LLC | 14 | $298 |
| Vanda Pharmaceuticals Inc. | 11 | $284 |
| Lundbeck LLC | 11 | $240 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $222 |
| Noven Therapeutics, LLC | 10 | $157 |
| Alkermes, Inc. | 7 | $146 |
| Johnson & Johnson | 5 | $109 |
| E.r. Squibb & Sons, L.L.C. | 4 | $98 |
| Almatica Pharma LLC | 5 | $95 |
| Bausch Health US, LLC | 4 | $77 |
| Neurocrine Biosciences, Inc. | 3 | $77 |
| Neos Therapeutics, LP | 4 | $73 |
| Harmony Biosciences LLC | 2 | $68 |
| Validus Pharmaceuticals LLC | 2 | $43 |
| OWP Pharmaceuticals, Inc. | 2 | $34 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Avion Pharmaceuticals | 1 | $15 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$600
- Auvelity$126
- REXULTI$121
- CAPLYTA$119
- VRAYLAR$102
How this compares
$6,263 in reported general payments places this provider in the 90th percentile of 2,237 adult health providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 19 | $30,734 |
| VraylarCariprazine Hcl | 13 | $21,800 |
| CaplytaLumateperone Tosylate | 13 | $20,305 |
| Quetiapine Fumarate | 68 | $1,036 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 17 | $993 |
| Alprazolam | 109 | $865 |
| Lamotrigine | 60 | $820 |
| Fluvoxamine Maleate | 12 | $698 |
| Bupropion XlBupropion Hcl | 36 | $677 |
| Oxcarbazepine | 12 | $672 |
| Clonazepam | 46 | $659 |
| Duloxetine Hcl | 41 | $629 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 33 | $618 |
| Trazodone Hcl | 28 | $440 |
| Lorazepam | 26 | $377 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $606 | $30,73419 claims |
| AbbVieVraylar | $799 | $21,80013 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $709 | $20,30513 claims |
| Almatica Pharma LLCSertraline Hcl | $95 | $31629 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,237 adult health providers in Florida.
Other adult health in Riverview
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.